- Title: Subtitle
- Progression of Focal Segmental Glomerulosclerosis in Patients With High Risk APOL1 Genotypes: A CureGN Study: SA-PO735
- Creators
- Mahmoud Kallash - Nationwide Children's HospitalYujie Wang - University of Michigan–Ann ArborAbigail R. Smith - University of Michigan–Ann ArborHoward Trachtman - University of Michigan–Ann ArborCarla M. Nester - University of IowaRasheed A. Gbadegesin - Duke Medical CenterPietro A. Canetta - Columbia University Irving Medical CenterChen Wang - Columbia University Irving Medical CenterTracy E. Hunley - Vanderbilt University Medical CenterJohn Sperati - Johns Hopkins University School of MedicineDavid T. Selewski - University of South Carolina SystemIsabelle Ayoub - The Ohio State University Wexner Medical CenterTarak Srivastava - Mercy Hospital SpringfieldAmy K. Mottl - Cincinnati Children's Hospital Medical CenterJeffrey B. Kopp - National Institute of Diabetes and Digestive and Kidney DiseasesVirginie Royal - Hôpital Maisonneuve-RosemontDebbie Gipson - University of Michigan–Ann ArborJason M. Kidd - Children's Hospital of Richmond at VCU
- Resource Type
- Abstract
- Publication Details
- Journal of the American Society of Nephrology, Vol.33(11S), pp.806-806
- DOI
- 10.1681/ASN.20223311S1806b
- ISSN
- 1046-6673
- eISSN
- 1533-3450
- Language
- English
- Date published
- 11/2022
- Academic Unit
- Stead Family Department of Pediatrics; Internal Medicine; Nephrology, Dialysis and Transplantation
- Record Identifier
- 9984648571202771
Abstract
Progression of Focal Segmental Glomerulosclerosis in Patients With High Risk APOL1 Genotypes: A CureGN Study: SA-PO735
Journal of the American Society of Nephrology, Vol.33(11S), pp.806-806
11/2022
DOI: 10.1681/ASN.20223311S1806b
Details
Metrics
2 Record Views